The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1723
March 3, 2025
View Complete Issue         Table of Contents 2019 
Drugs for Dry Eye Disease
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Dry Eye Disease
March 3, 2025 (Issue: 1723)
Disruption of tear-film homeostasis (altered composition, reduced production, rapid evaporation) and resulting ocular surface inflammation cause the discomfort and blurred vision of dry eye disease. Many cases are caused by tear evaporation due...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Dry Eye Disease
Article code: 1723b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.